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The dual origin of the yeast
mitochondrial proteome
In their paper, Karlberg et al. describe a scheme for
the origin of the mitochondrial protein complement,
based on phylogenetic reconstructions involving
over 400 yeast nuclear genes that encode mitochon-
drial proteins. They believe that a free-living a-
proteobacterium evolved into an endosymbiont of
an anaerobic host, losing most of its ancestral
bacterial genes, and eventually transferring some
with roles in bioenergetic and translational pro-
cesses to the nuclear genome. The endosymbiont
also gained a large number of genes from the
nuclear genome, which transformed it into an
ATP-exporting organelle.
Peroxisomal b-oxidation Ð C. elegans as
the new model
Neurodegeneration is a common symptom of several
human peroxisomal disorders, but the role of
peroxisomal processes in the maintenance of neu-
rons is not completely known. The nematode neural
network is well characterized and relatively simple in
function, thus C. elegans is a possible model for the
study of this neurodegeneration. Gurvitz et al. have
used homology searches to identify nematode
orthologues of yeast b-oxidation enzymes and
C. elegans PEX-5, the receptor for peroxisomal
targeting signal type 1. PSORT II was used to
predict the subcellular localizations of the genes, and
the C. elegans PEX-5 was used in two-hybrid
screens, to verify the predicted peroxisomal location
of several of the nematode b-oxidation enzymes.
Global cDNA ampli®cation combined
with real time RT±PCR
One factor currently limiting the breadth of
application of microarray technology is the require-
ment for micrograms of starting, total RNA for the
production of labelled targets. Samples yielding low
levels of RNA, such as clinical samples of diseased
or infected tissues, do not provide anything like
these levels of RNA. Al-Taher et al. present a
strategy for the ampli®cation of small-scale sam-
ples, whilst maintaining the relative representation
of each message within the sample. The approach
has been adapted to allow use with TaqMan
2 real
time quantitative PCR, and in this study, applied to
the quantitation of potassium channel mRNAs in a
range of tissue types and in small numbers of cells
grown in culture.
Expression pro®ling at the single cell
level Ð small is beautiful
In his review, Ged Brady discusses the methods
currently available for the assessment of expression
levels of multiple genes in small-scale samples down
to single-cells. The review provides information on
the technical aspects of each method, highlighting
their strengths and weaknesses, and goes on to
describe the ®elds of biological research that have
bene®ted from the application of these methods.
How many human genes are there? Ð
the gene guessing game
Double Twist's recent human gene count predic-
tion, based on the y90% of the genome held in the
public databases, followed by the joint announce-
ment of the near-completion of the human genome
has sparked a lively debate as to how many genes
our genome encodes. Ian Dunham assesses each of
the estimates made public so far, from those over
100 000 from Incyte and TIGR, to those around
35 000 arising from his own study of chromosome
22 and other strategies, such as comparison with the
puffer®sh, Tetraodon nigroviridis.
Featured organism Ð the zebra®sh,
Danio rerio
In this issue we feature the zebra®sh, a model
organism close to the heart of many researchers
working on development, particularly those with an
interest in organ development. The zebra®sh has
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these areas, due in the main part to genetic screens
of large panels of mutagenized ®sh, done in parallel
by Christiane Nu Èsslein-Volhard, Wolfgang Driever
and Mark Fishman's laboratories. On the eve of a
second screen, aimed at achieving saturation of
developmental genes, we discuss the progress made
so far and take in comments on the future of
zebra®sh genomics research from Mark Fishman
and Stephen Wilson.
Interview Ð Stefan Schulte-Merker
Artemis Pharmaceuticals has recently launched a
second mutagenesis screen of the zebra®sh, with the
aim of detecting genes with roles in development
that were missed in the ®rst screens. We discuss
the results of the ®rst screens and the plans for
the second screen with Stefan Schulte-Merker of
Artemis Pharmaceuticals, who will be conducting
the screen in collaboration with several academic
groups.
Meeting reviews
Spring/Summer this year was a busy time for
meetings. Accordingly, we have brought you a
selection of brief reports from three of the most
relevant meetings this season.
Karin van de Sande reports on the Arabidopsis
Research meeting held in Madison in June, Andy
Hayes reviews the Microarray Data Standards
meeting which took place in Heidelberg this May
and Mark Strivens covers the `Genome Sequencing
and Biology' meeting held at the Cold Spring
Harbor Laboratories in May, at which the `Gene-
Sweepstake' on the number of human genes was
initiated.
Website review Ð UK CropNet
This website provides a comprehensive, UK-based
resource and ideal ®rst port of call for all those
interested in crop plant genomics. The site provides
access to several UK-based databases, including the
Arabidopsis Genome Resource (AGR) and mirrors
a wide range of databases hosted at the Cornell
University site, such as RiceGenes. The site also
provides a selection of comparative mapping tools,
including tools that allow users to display whole
genome comparisons as Oxford grids or real `crop
circles'.
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